Inventor

Johann Leban

Inventor
Germering, DE

Overview

22→
Patents
1990–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides8%
C07CAcyclic or carbocyclic compounds5%
Y02ATechnologies for adaptation to climate change5%
C12NMicroorganisms or enzymes2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
11,091,4903-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors202110,633,369Method of inhibiting DYRK1B202010,221,147Heterocyclic compounds with working memory enhancing activity201910,005,7692,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors20189,951,050Method of inhibiting DYRK1B20189,580,438'Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders'20178,653,138'Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents'20148,592,456'IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation'20138,354,433'Anti-inflammatory agents as virostatic compounds'20138,354,436'IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation'20138,106,048'Heterocyclic NF-κB inhibitors'20127,812,041'Heterocyclic NF-κB inhibitors'20107,601,745'Heterocyclic NF-kB inhibitors'20097,531,517'Inhibitors of cancer cell, T-cell and keratinocyte proliferation'20097,365,094'Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents'20087,317,030'Compounds as inhibitors of cell proliferation and viral infections'20087,247,736'Method of identifying inhibitors of DHODH'20077,071,355'Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents'20066,235,717'Pharmaceutical compounds'20015,670,482'Neuropeptide Y antagonists'19975,620,959'Bombesin antagonists'19974,943,627'Peptides involved in the pathogenesis of HIV infection'1990

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2001Patents assigned to GLAXO WELLCOME INC (3)· patent assignee history
1997–2001Based in Durham, NC, US· patent location history
2006–2020Patents assigned to 4 SC AG (3)· patent assignee history
2006–2010Based in Germering, DE· patent location history
2007–2018Patents assigned to 4SC AG (10)· patent assignee history
2009–2014Based in Martinsried, DE· patent location history
2012–2014Patents assigned to LEBAN JOHANN (5)· patent assignee history
2013–2018Patents assigned to 4SC DISCOVERY GMBH (5)· patent assignee history
2017–2020Based in Vienna, AT· patent location history
2021Based in Igls, AT· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
4SC AG102007–2018
4SC DISCOVERY GMBH52013–2018
LEBAN JOHANNself52012–2014
4 SC AG32006–2020
GLAXO WELLCOME INC31997–2001
Locations
LocationPatentsSpan
Germering, DE62006–2010
Vienna, AT52017–2020
Martinsried, DE52009–2014
Durham, NC, US21997–2001
Igls, AT12021